Reference is made to the notice on 15 May 2024 (corrected 20 May 2024) regarding a private placement of 33.3 million shares at NOK 1.65 per share, split in two tranches. The share capital of tranche 1 of the private placement has been registered and the shares will be delivered soonest. Following the issue, the company's share capital is NOK 46,210,015.20 divided into 308,066,768 shares, each with a nominal value of NOK 0.15. For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne ...

This notice is issued by IDEX Biometrics ASA on behalf of the shareholder mentioned below. IDEX Biometrics ASA disclosed on 15 May 2024 that it had conducted a private placement of 33.3 million new shares in IDEX Biometrics. Tranche 1 of the private placement amounted to 27.9 million shares. In connection with the private placement, the managers of the private placement, IDEX Biometrics and certain existing shareholders entered into a share lending agreement. Mr. Robert Keith participated in the private pla ...

文章核心观点 - 公司成功完成了一次私募股票发行 [1] - 由于疏忽,之前的公告中存在一些错误,需要进行更正 [2][3] - 更正后,Tranche 1股票数量为27,940,213股,Tranche 2股票数量为5,393,120股,每股面值0.15挪威克朗,发行价格为1.65挪威克朗 [3] - 本次发行后,公司股本增加了4,191,031.95挪威克朗,达到46,210,015.20挪威克朗,总股数为308,066,768股 [4] 公司信息 - IDEX Biometrics ASA是一家指纹生物识别技术领导者,为支付、访问控制和数字身份认证提供解决方案 [5] - 公司的生物识别解决方案基于专利和专有的传感器技术、集成电路设计和软件,主要面向基于卡的应用 [5] - 公司作为行业推动者,与主要的卡制造商和技术公司合作,将解决方案推向市场 [5] 联系方式 - 投资者关系联系人:Marianne Bøe [5] - 电子邮箱:marianne.boe@idexbiometrics.com [5] - 电话:+47 918 00186 [5] 其他信息 - 本公告由公司财务副总裁Erling Svela于2024年5月20日23:50 CET发布 [6] - 该信息根据挪威《证券交易法》第5-8条和第5-12条进行披露和发布 [6]

IDEX Corporation (IEX) has been benefiting from strong momentum in the Fire & Safety/Diversified Products (FSDP) segment and accretive acquisitions despite weakness in the Health & Science Technologies (HST) unit, the rising cost of sales and forex woes. Let us discuss the factors why investors should retain the stock for the time being. Growth Catalysts Business Strength: IDEX is benefiting from the strong performance of the FSDP segment, driven by increasing orders from industrial and municipal markets. T ...

IDEX Biometrics ASA held its annual general meeting on 16 May 2024. 95.3 million shares or 34% of the capital was represented at the meeting. All resolutions were passed as proposed by the board and nomination committee. The following board was elected at the meeting:Chair: Morten OpstadBoard members: Annika Olsson and Adriana Saitta. The minutes of the meeting will be available at the company’s web site, www.idexbiometrics.com, in due course. For further information contact: Marianne Bøe, Head of investo ...

Aligned with the restructuring of IDEX’s organization to consolidate development and business operations to be located primarily in the UK and the EU/EEA, and to reduce costs, the nomination committee proposes that IDEX also reduces the size of the board of directors to a total of three. The nomination committee proposes that the following board shall be elected: Mr. Morten Opstad to continue for the second year of his term, in the role of chair of the board. Ms. Annika Olsson and Ms. Adriana Saitta to con ...

Oslo, Norway – 16 May 2024 - IDEX Biometrics will give a webcast presentation today at 09:00 CET in connection with its interim report for the first quarter of 2024. The presentation will be held by Vince Graziani, Chief Executive Officer, and Catharina Ekløf, Chief Commercial and Operating Officer. The webcast presentation can be viewed at the following link: https://idexbiometrics.videosync.fi/q1-2024 The presentation file is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors ...

Oslo, Norway – 16 May 2024 - IDEX Biometrics ASA’s interim report for the first quarter of 2024 is attached to this notice (link below) The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Vince Graziani, Chief Executive Officer, today at 09:00 CET. The webcast presentation slide deck is attached to this notice (link below). Last year we focused on laying the foundation for biometr ...

文章核心观点 - 公司进行了约55亿挪威克朗的私募股票发行,发行价为1.65挪威克朗每股 [1] - 公司还计划进行后续发行,最高募集1320万挪威克朗,发行价与私募发行相同 [1] - 后续发行需要在6月12日左右召开的临时股东大会上获得批准 [1] 私募发行 - 发行日期为2024年5月15日 [2] - 最后含权日为2024年5月15日 [2] - 除权日为2024年5月16日 [2] - 记录日期为2024年5月21日 [2] - 预计在2024年6月12日左右的临时股东大会上获得批准 [2] - 最高发行股数为800万股 [2] - 发行价格为1.65挪威克朗每股 [2] 后续发行 - 后续发行将根据经挪威金融监管局批准的发行说明书进行 [3] - 后续发行的具体情况将在发行说明书中披露 [3]

The board of directors of IDEX Biometrics ASA resolved on 15 May 2024 to issue 40,900 incentive subscription rights to a new individual contractor in the IDEX Biometrics group. The grant was made under the company's 2023 incentive subscription rights plan as resolved at the annual general meeting on 23 May 2023. The exercise price of the subscription rights is NOK 1.80 per share and the SRs vest by 25% per year over four years. The SRs expire on 23 May 2028. Following the grant there are 17,514,625 subscrip ...